Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
University of Southern California, Los Angeles, California Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles, California Cedars-Sanai Medical Center, Los Angeles, California Hoag Memorial Hospital Presbyterian, Newport, California Sarah Cannon Research Institute - Denver DDU, Denver, Colorado Emory University - Winship Cancer Institute, Atlanta, Georgia New York Cancer & Blood Specialists, New York, New York University of Rochester - Wilmot Cancer Institute, Rochester, New York START San Antonio, San Antonio, Texas Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin